Prostate Cancer awareness in the Lebanese population: a cross sectional national survey.
Awareness
Early diagnosis
Lebanon
Prevention
Prostate cancer
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
25 09 2021
25 09 2021
Historique:
received:
25
01
2021
accepted:
14
09
2021
entrez:
26
9
2021
pubmed:
27
9
2021
medline:
3
11
2021
Statut:
epublish
Résumé
Prostate cancer (Pca) is the second most common cause of cancer among Lebanese men. Screening is an effective method to reduce prostate cancer mortality. This study assessed the knowledge, awareness, and screening practices among Lebanese population regarding Pca. A cross-sectional national study over all the Lebanese governorates on 1558 persons was undergone. Information on Pca knowledge and attitudes towards screening was obtained using a semi structured questionnaire. Bivariate and binary logistic regression were used to assess relations between Pca knowledge and socio-demographic characteristics. The sample consisted of 1088 (69.8%) males and 470 (30.2%) females, with a mean age of 40 Y.O. Concerning early detection methods of Pca, its frequency, the ideal screening age, symptoms and curability of Pca, a significant difference (p < 0.05) was found when studying the following variables: the educational level (university level group having the highest percentage of correct answers), the individual monthly income (more correct answers were found with higher monthly income) and the age groups (most correct answers in the younger age groups). Our study points to the need of developing Pca prevention and education programs that should especially target older men, and people of low socioeconomic status and education in Lebanon. Such programs would increase awareness to Pca and screening, ultimately reducing the burden of advanced cancer through its early diagnosis.
Sections du résumé
BACKGROUND
Prostate cancer (Pca) is the second most common cause of cancer among Lebanese men. Screening is an effective method to reduce prostate cancer mortality. This study assessed the knowledge, awareness, and screening practices among Lebanese population regarding Pca.
METHODS
A cross-sectional national study over all the Lebanese governorates on 1558 persons was undergone. Information on Pca knowledge and attitudes towards screening was obtained using a semi structured questionnaire. Bivariate and binary logistic regression were used to assess relations between Pca knowledge and socio-demographic characteristics.
RESULTS
The sample consisted of 1088 (69.8%) males and 470 (30.2%) females, with a mean age of 40 Y.O. Concerning early detection methods of Pca, its frequency, the ideal screening age, symptoms and curability of Pca, a significant difference (p < 0.05) was found when studying the following variables: the educational level (university level group having the highest percentage of correct answers), the individual monthly income (more correct answers were found with higher monthly income) and the age groups (most correct answers in the younger age groups).
CONCLUSION
Our study points to the need of developing Pca prevention and education programs that should especially target older men, and people of low socioeconomic status and education in Lebanon. Such programs would increase awareness to Pca and screening, ultimately reducing the burden of advanced cancer through its early diagnosis.
Identifiants
pubmed: 34563148
doi: 10.1186/s12889-021-11821-6
pii: 10.1186/s12889-021-11821-6
pmc: PMC8466637
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1744Informations de copyright
© 2021. The Author(s).
Références
Clin Genitourin Cancer. 2019 Aug;17(4):e837-e844
pubmed: 31213414
BMC Cancer. 2018 Jan 18;18(1):84
pubmed: 29347916
Int J Cancer. 2016 Mar 15;138(6):1388-400
pubmed: 26488767
Am J Mens Health. 2018 Nov;12(6):1807-1823
pubmed: 30203706
J Urol. 2007 May;177(5):1851-5
pubmed: 17437834
Am J Mens Health. 2018 Jul;12(4):751-759
pubmed: 29658371
J Cancer Educ. 2013 Dec;28(4):617-22
pubmed: 24078345
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Oncol Nurs Forum. 2015 Jan;42(1):54-62
pubmed: 25542321
J Cancer Educ. 2019 Dec;34(6):1107-1111
pubmed: 30116988
Eur Urol. 2017 Apr;71(4):618-629
pubmed: 27568654
Int J Urol. 2018 Jun;25(6):524-531
pubmed: 29740894
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593